Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.20.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 48,562 $ 49,703
Short-term investments 19,993 19,918
Contracts receivable and retainage, net 16,178 26,095
Contract assets 64,905 52,128
Prepaid expenses and other assets 2,005 3,948
Inventory 2,723 2,676
Assets held for sale 8,082 9,006
Total current assets 162,448 163,474
Property, plant and equipment, net 69,651 70,484
Other noncurrent assets 18,930 18,819
Total assets 251,029 252,777
Current liabilities:    
Accounts payable 70,542 61,542
Contract liabilities 11,571 26,271
Accrued expenses and other liabilities 8,077 10,031
Total current liabilities 90,190 97,844
Other noncurrent liabilities 2,228 2,248
Total liabilities 92,418 100,092
Shareholders’ equity:    
Preferred stock, no par value, 5,000 shares authorized, no shares issued and outstanding
Common stock, no par value, 30,000 shares authorized, 15,290 shares issued and outstanding at March 31, 2020 and 15,263 at December 31, 2019 11,121 11,119
Additional paid-in capital 103,143 103,124
Retained earnings 44,347 38,442
Total shareholders’ equity 158,611 152,685
Total liabilities and shareholders’ equity $ 251,029 $ 252,777